节点文献
老年非小细胞肺癌个体化治疗的新进展
New Progress of Individualized Treatment for Senile Non-small Cell Lung Cancer
【摘要】 随着我国人口步入老龄时代,肺癌在老年性疾病中占有主导地位,因此诊治老年肺癌成为临床医师迫在眉睫的课题。手术治疗仍是目前肺癌根治的主要手段。对于失去手术机会的老年患者含铂类化疗仍是化疗的主要方案,联合化疗在降低药物毒性方面凸显优势。老年患者合并多种基础疾病,常规剂量治疗存在较高风险。该文就目前临床研究对老年患者肺癌个体化治疗进行综述。
【Abstract】 With the population aging in our country,and the dominant position of lung cancer in senile diseases,the diagnosis and treatment of elderly lung cancer become our urgent task. Surgical treatment is still the main means of the lung cancer for radical cure effect at present. For elderly patients who have missed the surgery opportunity platinum-based chemotherapy is still the main scheme of chemotherapy. Combined chemotherapy has noticeable advantages in reducing drug toxicity. Since the elderly patients are often with combined basic diseases,there is a higher risk in conventional dose treatment. Here is to make a review of the current clinical study on individualized treatment of elderly patients with lung cancer.
【Key words】 Non-small cell lung cancer,elderly; Individualization; Treatment;
- 【文献出处】 医学综述 ,Medical Recapitulate , 编辑部邮箱 ,2014年15期
- 【分类号】R734.2
- 【被引频次】7
- 【下载频次】136